Literature DB >> 2461912

Noncorrelation between implantation and growth of tumor cells for their final metastatic efficiency.

E Barberá-Guillem1, J R Barceló, B Urcelay, A I Alonso-Varona, F Vidal-Vanaclocha.   

Abstract

We have measured the relative contribution of implantation and focal growth metastatic phenomena on the hepatic colonization process of intrasplenically injected B16 melanoma or Lewis lung carcinoma (LLC) tumor cells. To do this, an experimental variation of the parental tumor cell phenotype (seed factor) was performed by a selection of 10 times passaged hepatic-metastasizing tumor cells and changes in biological features of host tissue (soil) were induced following the treatment of the mice with ciclosporin, Thymostimulin, Bleomycin, silica particles or 17 alpha-ethynylestradiol prior to tumor injection. Implantation efficiency of selected variants was highly increased but, while the focal metastatic growth efficiency did not vary in LLC variants, in selected B16 melanoma cells it was clearly higher. In all the pretreated animals final metastatic volume varied with respect to the controls. In some mice, implantation efficiency was increased but this effect did not always determine later increments in the final metastatic volume. In other mice, focal growth of metastases was reduced with respect to the controls without correlative reductions in the final metastatic volume. In general, changes of final metastatic volume in the liver were mostly dependent upon the ability of tumor cells to successfully implant. Thus, final metastatic volume seems to depend on the sum of two relatively independent colonization phenomena: tumor cell implantation and focal growth of metastases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2461912

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  7 in total

1.  Functional variations in liver tissue during the implantation process of metastatic tumour cells.

Authors:  F Vidal-Vanaclocha; A Alonso-Varona; R Ayala; E Barberá-Guillem
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Deformation-driven destruction of cancer cells in the microvasculature.

Authors:  L Weiss
Journal:  Clin Exp Metastasis       Date:  1993-09       Impact factor: 5.150

3.  Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cells.

Authors:  T Palomares; A Alonso-Varona; A Alvarez; B Castro; Y Calle; P Bilbao
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

4.  A precise and efficient stereological method for determining murine lung metastasis volumes.

Authors:  B S Nielsen; L R Lund; I J Christensen; M Johnsen; P A Usher; L Wulf-Andersen; T L Frandsen; K Danø; H J Gundersen
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

5.  Two human melanoma xenografts with different metastatic capacity and glycosaminoglycan pattern.

Authors:  J Timár; I Kovalszky; S Paku; K Lapis; L Kopper
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

6.  The addition of interleukin-2 to cyclophosphamide therapy can facilitate tumor growth of B16 melanoma.

Authors:  T Palomares; P Bilbao; A Alonso-Varona; E Barberá-Guillem
Journal:  Cancer Immunol Immunother       Date:  1995-05       Impact factor: 6.968

7.  Proprotein convertase subtilisin/kexin type 9 deficiency reduces melanoma metastasis in liver.

Authors:  Xiaowei Sun; Rachid Essalmani; Robert Day; Abdel M Khatib; Nabil G Seidah; Annik Prat
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.